Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Min-Kyung | - |
dc.contributor.author | Han, Kyung-Do | - |
dc.contributor.author | Lee, Jae-Hyuk | - |
dc.contributor.author | Sohn, Seo-Young | - |
dc.contributor.author | Hong, Oak-Kee | - |
dc.contributor.author | Jeong, Jee-Sun | - |
dc.contributor.author | Kim, Mee-Kyoung | - |
dc.contributor.author | Baek, Ki-Hyun | - |
dc.contributor.author | Song, Ki-Ho | - |
dc.contributor.author | Kwon, Hyuk-Sang | - |
dc.date.accessioned | 2022-07-13T11:30:21Z | - |
dc.date.available | 2022-07-13T11:30:21Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/151604 | - |
dc.description.abstract | Albuminuria is closely associated with diabetic retinopathy (DR), but the precise role of the albumin-to-creatinine ratio (ACR) in screening for DR remains to be determined. This study aimed to investigate an ACR threshold for predicting DR in patients with type 2 diabetes. A cross-sectional study was conducted on 1,102 type 2 diabetes patients, aged ≥30 years and recruited from the Korea National Health and Nutrition Examination Survey, 2010–2011. Participants were grouped by stage of DR: mild-to-moderate nonproliferative DR (NPDR), severe NPDR, and proliferative diabetic retinopathy (PDR). An early morning spot urine sample was obtained for ACR measurement. ROC curve analysis revealed that the optimal cut-off value of ACR for predicting DR was 2.26 mg/mmol (20 μg/mg). The prevalence of ACR ≥ 2.26 mg/mmol tended to increase with severity of DR. The risk for DR in patients with ACR ≥ 2.26 mg/mmol was higher than in those with ACR < 2.26 mg/mmol. The risk for severe NPDR and PDR also increased at ACR ≥ 2.26 mg/mmol. Normal-to-mildly increased albuminuria (an ACR of 2.26 mg/mmol) may predict the risk for DR development and progression in patients with type 2 diabetes. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sohn, Seo-Young | - |
dc.identifier.doi | 10.1038/s41598-017-11906-6 | - |
dc.identifier.scopusid | 2-s2.0-85029607263 | - |
dc.identifier.wosid | 000410916100015 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.7, no.1, pp.1 - 8 | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 7 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 8 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | GLOMERULAR-FILTRATION-RATE | - |
dc.subject.keywordPlus | KIDNEY-DISEASE | - |
dc.subject.keywordPlus | MACULAR EDEMA | - |
dc.subject.keywordPlus | MICROALBUMINURIA | - |
dc.subject.keywordPlus | PROTEINURIA | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | DEATH | - |
dc.identifier.url | https://www.nature.com/articles/s41598-017-11906-6 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.